In den Warenkorb
Bestellen Sie auch über:
![]() |
+49 (0)241 95 163 153 |
![]() |
+49 (0)241 95 163 155 |
C1q and Tumor Necrosis Factor Related Protein 5 (C1QTNF5) (internal) Antikörper
| Antigen | C1q and Tumor Necrosis Factor Related Protein 5 (C1QTNF5) |
| Synonyme | LORD, CTRP5, FLJ30570, DKFZp586B0621, MGC109436, C1QTNF5, MGC112378, wu:fb02c10, wu:fb02f05, zgc:112378, MGC160096 |
| Epitope |
Alternativen internal |
| Klonalität | Polyklonal |
| Wirt |
Alternativen Kaninchen |
| Applikation |
Alternativen Immunhistochemie (IHC), Western Blot (WB)
|
![]() |
4 Publikationen vorhanden |
| Produktnummer | ABIN350267 |
| Menge | 100 µl (Varianten) |
| Preis | 317,95 € Zzgl. Versandkosten €20,00 und MWSt |
| Lieferung nach |
|
| Verfügbarkeit | Lieferung in 7 bis 10 Werktagen |
Produktbeschreibung
| Weitere Bezeichnung | CTRP5 (Complement C1q tumor necrosis factor-related protein 5, C1QTNF5) (internal region) |
| Swiss-Prot | Q9BXJ0 |
| Immunogen | A synthetic peptide from the internal region of human CTRP5 (Complement C1q tumor necrosis factor-related protein 5, C1QTNF5) conjugated to an immunogenic carrier protein was used as the immunogen. The antigen is homologous in rat and mouse. |
| Format | Lyophilized |
| Beschreibung | Defects in C1QTNF5 are a cause of late-onset retinal degeneration (LORD). LORD is an autosomal dominant disorder characterized by onset in the fifth to sixth decade with night blindness and punctate yellow-white deposits in the retinal fundus, progressing to severe central and peripheral degeneration, with choroidal neovascularization and chorioretinal atrophy. Subcellular location: Secreted Also known as: Complement C1q tumor necrosis factor-related protein 5, C1QTNF5. |
| Spezifität | Appears to be specific for CTRP5. |
Anwendungen
| Applikationshinweise | IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications. |
| Reinheit | whole serum |
| Lagerung | Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
| Beschränkungen | Nur für Forschungszwecke einsetzbar |
Publikationen
| Publikationen |
Hayward, Shu, Cideciyan et al.: "Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration." in: Human molecular genetics, Vol. 12, Issue 20, pp. 2657-67, 2003 (PubMed).
Clark, Gurney, Abaya et al.: "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." in: Genome research, Vol. 13, Issue 10, pp. 2265-70, 2003 (PubMed). Zhang, Henzel: "Signal peptide prediction based on analysis of experimentally verified cleavage sites." in: Protein science : a publication of the Protein Society, Vol. 13, Issue 10, pp. 2819-24, 2004 (PubMed). Taylor, Noguchi, Totoki et al.: "Human chromosome 11 DNA sequence and analysis including novel gene identification." in: Nature, Vol. 440, Issue 7083, pp. 497-500, 2006 (PubMed). |
Alternativen
Alternativen zu Antigen "C1q and Tumor Necrosis Factor Related Protein 5 (C1QTNF5)", Typ "Antikörper" finden
| Wirte | Kaninchen (16), Maus (2), Schaf (2) |
| Reaktivitäten | Human (18), Ratte (Rattus) (6), Maus (2) |
| Applikationen | Western Blot (WB) (20), Immunhistochemie (Paraffinschnitte) (IHC (p)) (6), Enzyme Immunoassay (EIA) (4), ELISA (Detektionsantikörper) (2), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (2), Immunhistochemie (IHC) (2) |
| Epitope | internal (2), N-Term (1) |




Alternativen